Press Room

AAPS 2021 PharmSci 360

Start
Sunday, October 17, 2021 - 00:00
End
Wednesday, October 20, 2021 - 00:00
Location: Philadelphia, USA
Booth Number: 1202
fully integrated solution provider for inhalation | Hovione

We are ready to safely return to AAPS PharmSci 360 in Philadelphia and we look forward to seeing you.

 

Schedule a meeting at the Hovione's booth (#1202) or online

Schedule a meeting button | Hovione

 

HOVIONE PRESENTATIONS AT AAPS

Join Hovione Scientists in their virtual oral presentations and poster abstracts and find out more about their latest research and innovation.

maria paisana Analytical Development Scientist | Hovione

 

Maria Paisana - Senior Analytical Scientist, Analytical Development Group

Presentation: Make it Flow: Can Ring Shear Tester Predict Flowability Through Hoppers?

Poster: Ring Shear Tester: The importance of Shear and Wall Friction Methodology for Arching Tendency Predictions

 





 

 
Luis Sobral Fellow Scientist R&D | Hovione

 

Luís Sobral - Fellow Scientist, R&D

Presentation: Modeling Chemical Reactions with Quantum Mechanics







 

Ricardo Gonçalves R&D Analytical Development | Hovione

Ricardo Gonçalves - Analytical Scientist, R&D Analytical Development

Presentation: Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures





 

Beatriz Noriega-Fernandes Inhalation and Advanced Drug Delivery R&D | Hovione

 

Beatriz Noriega-Fernandes - Scientist, Inhalation and Advanced Drug Delivery Group, R&D

Poster: Spray-Dried Composite Formulation Containing DSPC for Lung Sustained Release





 

 
Luis Sousa R&D Analytical Development | Hovione

 

Luís Sousa - Senior Analytical Scientist, R&D Analytical Development

Poster: Evaluation of the Relaxation State of Amorphous Itraconazole Using Solution Calorimetry











 

From feasibility to commercial: Integrated Dry Powder Inhalation solutions to help bring inhaled medicines to patients

 

 

Hovione offers Customized high-performance APIs, Particle Engineering and Formulation along with a full range of highly specialized, innovative inhalation Devices. Our motto is Everything for Inhalation meaning great People, great Science and Technology combined with a strong Quality and Safety culture.





 

 

Let’s discuss your project together. 

 

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026